The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
Open accessAbstract
Mutations of the tricarboxylic acid cycle enzyme fumarate hydratase cause hereditary leiomyomatosis and renal cell cancer. Fumarate hydratase-deficient renal cancers are highly aggressive and metastasize even when small, leading to a very poor clinical outcome. Fumarate, a small molecule metabolite that accumulates in fumarate hydratase-deficient cells, plays a key role in cell transformation, making it a bona fide oncometabolite. Fumarate has been shown to inhibit α-ketoglutarate-dependent dioxygenases that are involved in DNA and histone demethylation. However, the link between fumarate accumulation, epigenetic changes, and tumorigenesis is unclear. Here we show that loss of fumarate hydratase and the subsequent accumulation of fumarate in mouse and human cells elicits an epithelial-to-mesenchymal-transition (EMT), a phenotypic switch associated with cancer initiation, invasion, and metastasis. We demonstrate that fumarate inhibits Tet-mediated demethylation of a regulatory region of the antimetastatic miRNA cluster mir-200ba429, leading to the expression of EMT-related transcription factors and enhanced migratory properties. These epigenetic and phenotypic changes are recapitulated by the incubation of fumarate hydratase-proficient cells with cell-permeable fumarate. Loss of fumarate hydratase is associated with suppression of miR-200 and the EMT signature in renal cancer and is associated with poor clinical outcome. These results imply that loss of fumarate hydratase and fumarate accumulation contribute to the aggressive features of fumarate hydratase-deficient tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, fumarate inhibits TET enzymes, which stimulate EMT, leading to cancer metastasis131,132.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [131]
In the citing paper
“Further confirmation of fumarate as an oncometabolite was verified by experimental data showing that tumor cells lost their ability to invade and migrate when the function of fumarate hydratase was restored by an external expression vector131.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [131]
In the citing paper
“In recent years, two landmark genomic studies carried out in human glioma and acute myeloid leukaemia (AML) found mutations in IDH1/2 and it is now appreciated that these enzymes (which drive elevated production of D-2-HG) are the most frequently mutated metabolic genes in human cancer112-114.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [112]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
MethPrimer: designing primers for methylation PCRs
Li, L.-C., & Dahiya, R. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.11.1427 · Cited by 2,741
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365
Direct regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 585
Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer
Huo, M., Zhang, J., Huang, W., & Wang, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.793428 · Cited by 117
Muller, M., Guillaud-Bataille, M., Salleron, J., Genestie, C., Deveaux, S., Slama, A., Paillerets, B. B., Richard, S., Benusiglio, P. R., & Ferlicot, S. (2018) · Modern Pathology · doi:10.1038/s41379-018-0017-7 · Cited by 109
The mitochondrial dynamics in cancer and immune-surveillance
Simula, L., Nazio, F., & Campello, S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.007 · Cited by 106
Fang, L., Huang, H., Lv, J., Chen, Z., Chen, L., Jiang, T., Xu, P., Li, Y., Wang, S., Li, B., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06049-8 · Cited by 105
Cancer Metabolism: Fueling More than Just Growth
Lee, N., & Kim, D. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0310 · Cited by 102
Non‐canonical Bases in the Genome: The Regulatory Information Layer in DNA
Carell, T., Kurz, M. Q., Müller, M., Rossa, M., & Spada, F. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201708228 · Cited by 104
O-GlcNAcylation of fumarase maintains tumour growth under glucose deficiency
Wang, T., Yu, Q., Li, J., Hu, B., Zhao, Q., Ma, C., Huang, W., Zhuo, L., Fang, H., Liao, L., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3562 · Cited by 102
Meng, Y., Ren, Z., Xu, F., Zhou, X., Song, C., Wang, V. Y., Liu, W., Lu, L., Thomson, J. A., & Chen, G. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.023 · Cited by 100
Gabra, M. B. I., Yang, Y., Li, H., Senapati, P., Hanse, E. A., Lowman, X. H., Tran, T. Q., Zhang, L., Doan, L. T., Xu, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17181-w · Cited by 99
Jia, D., Park, J. H., Kaur, H., Jung, K. H., Yang, S., Tripathi, S., Galbraith, M., Deng, Y., Jolly, M. K., Kaipparettu, B. A., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01385-y · Cited by 97
Metabolic Plasticity of Tumor Cell Mitochondria
Cannino, G., Ciscato, F., Masgras, I., Sànchez‐Martìn, C., & Rasola, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00333 · Cited by 97
Peng, M., Yang, D., Hou, Y., Liu, S., Zhao, M., Qin, Y., Chen, R., Teng, Y., & Liu, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1475-7 · Cited by 96
RetractedMalic enzyme 2 connects the Krebs cycle intermediate fumarate to mitochondrial biogenesis
Wang, Y.-P., Sharda, A., Xu, S., van Gastel, N., Man, C. H., Choi, U., Leong, W. Z., Li, X., & Scadden, D. T. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.003 · Cited by 98
Fumarate Hydratase Loss Causes Combined Respiratory Chain Defects
Tyrakis, P. A., Yurkovich, M. E., Sciacovelli, M., Papachristou, E. K., Bridges, H. R., Gaude, E., Schreiner, A., D’Santos, C. S., Hirst, J., Hernandez-Fernaud, J. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.092 · Cited by 96
Self-citationMitochondrial DNA mutations in ageing and cancer
Smith, A. L. M., Whitehall, J. C., & Greaves, L. C. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13291 · Cited by 105
The TCA cycle as a bridge between oncometabolism and DNA transactions in cancer
Ciccarone, F., Vegliante, R., Leo, L. D., & Ciriolo, M. R. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.008 · Cited by 97
Forde, C., Lim, D., Alwan, Y., Burghel, G. J., Butland, L., Cleaver, R., Dixit, A., Evans, D. G., Hanson, H., Lalloo, F. I., et al. (2019) · European Urology Oncology · doi:10.1016/j.euo.2019.11.002 · Cited by 95
Self-citationEpigenetic regulators in cancer therapy and progression
Marei, H. E. S. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01003-7 · Cited by 116
ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming
Mishra, P., Tang, W., Putluri, V., Dorsey, T. H., Jin, F., Wang, F., Zhu, D., Amable, L., Deng, T., Zhang, S., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93815 · Cited by 91
Zhou, L., Ou, S., Liang, T. B., Li, M., Xiao, P., Cheng, J., Zhou, J., & Yuan, L. (2023) · FEBS Journal · doi:10.1111/febs.16768 · Cited by 89
Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer
Tran, T. Q., Lowman, X. H., & Kong, M. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2506 · Cited by 91
Little, A. C., Kovalenko, I., Goo, L. E., Hong, H. S., Kerk, S. A., Yates, J. A., Purohit, V., Lombard, D. B., Merajver, S. D., & Lyssiotis, C. A. (2020) · Communications Biology · doi:10.1038/s42003-020-0988-z · Cited by 88
SDHi fungicides: An example of mitotoxic pesticides targeting the succinate dehydrogenase complex
Tête, A., Debizet, K., Imler, J., Tomkiewicz, C., Blanc, É., Barouki, R., Coumoul, X., & Bortoli, S. (2023) · Environment International · doi:10.1016/j.envint.2023.108219 · Cited by 95
Metabolite sensing and signaling in cancer
Wang, Y.-P., Li, J., Qu, J., Yin, M., & Lei, Q. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007624 · Cited by 87
Weil, R., Laplantine, E., Curic, S., & Génin, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01243 · Cited by 83
Mitochondrial Metabolism in Carcinogenesis and Cancer Therapy
Moindjie, H., Rodrigues, S., & Nahmias, C. (2021) · Cancers · doi:10.3390/cancers13133311 · Cited by 88
Multiple Levels of PGC-1α Dysregulation in Heart Failure
Oka, S., Sabry, A. D., Cawley, K. M., & Warren, J. S. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00002 · Cited by 85
Plasma metabolomic profiling of proliferative diabetic retinopathy
Zhu, X.-R., Yang, F., Lü, J., Zhang, H., Sun, R., Zhou, J., & Yang, J. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0358-3 · Cited by 78
Gupta, S., Swanson, A. A., Chen, Y., Lopez, T., Milosevic, D., Kipp, B. R., Leibovich, B. C., Thompson, R. H., Herrera-Hernandez, L. P., Cheville, J. C., et al. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.07.004 · Cited by 78
TOMM20 as a potential therapeutic target of colorectal cancer
Park, S.-H., Lee, A.-R., Choi, K., Joung, S., Yoon, J., & Kim, S. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.12.249 · Cited by 77
Ge, X. Q., Li, M., Yin, J., Shi, Z., Fu, Y. S., Zhao, N., Chen, H., Meng, L., Li, X., Hu, Z., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.01.029 · Cited by 83
Mitochondrial Metabolism: Yin and Yang for Tumor Progression
Valcárcel-Jiménez, L., Gaude, E., Torrano, V., Frezza, C., & Carracedo, A. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.06.004 · Cited by 78
Self-citationRoles and Regulations of TET Enzymes in Solid Tumors
Bray, J. K., Dawlaty, M. M., Verma, A. K., & Maitra, A. (2021) · Trends in cancer · doi:10.1016/j.trecan.2020.12.011 · Cited by 77
Operation of a TCA cycle subnetwork in the mammalian nucleus
Kafkia, E., Andrés‐Pons, A., Ganter, K., Seiler, M., Smith, T. S., Andrejeva, A., Jouhten, P., Pereira, F. M., Franco, C., Kuroshchenkova, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq5206 · Cited by 76
Metabolic determinants of tumour initiation
Brunner, J. S., & Finley, L. W. S. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00773-5 · Cited by 78
Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond
Teoh, S. T., & Lunt, S. Y. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1406 · Cited by 77
Li, J., Liu, H., Srivastava, S. P., Hu, Q., Gao, R., Li, S., Kitada, M., Wu, G., Koya, D., & Kanasaki, K. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15587 · Cited by 74
Koivunen, P., & Laukka, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2721-8 · Cited by 76
The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity
Scagliola, A., Mainini, F., & Cardaci, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7974 · Cited by 75
Self-citationRøsland, G. V., Dyrstad, S. E., Tusubira, D., Helwa, R., Tan, T. Z., Lotsberg, M. L., Pettersen, I. K. N., Berg, A., Kindt, C. K., Hoel, F., et al. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0197-8 · Cited by 69
The Role of Mitochondrial H+-ATP Synthase in Cancer
Esparza‐Moltó, P. B., & Cuezva, J. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00053 · Cited by 71
Chemical signaling between gut microbiota and host chromatin: What is your gut really saying?
Krautkramer, K. A., Rey, F. E., & Denu, J. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.761577 · Cited by 70
Lee, J., Guan, W., Han, S., Hong, D., Kim, L.-S., & Kim, H. (2018) · Cancer Science · doi:10.1111/cas.13588 · Cited by 71
Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy
Luo, Z., Eichinger, K. M., Zhang, A., & Li, S. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216396 · Cited by 71
Clotet‐Freixas, S., Zaslaver, O., Kotlyar, M., Pastrello, C., Quaile, A. T., McEvoy, C. M., Saha, A. D., Farkona, S., Boshart, A., Zorcic, K., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.abm2090 · Cited by 71
Targeting KRAS: from metabolic regulation to cancer treatment
Shi, Y., Zheng, H., Wang, T., Zhou, S., Zhao, S., Li, M., & Cao, B. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02216-3 · Cited by 81
Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth
Zamberlan, M., Boeckx, A., Muller, F., Vinelli, F., Ek, O., Vianello, C., Coart, E., Shibata, K., Christian, A., Grespi, F., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02304-6 · Cited by 72
Nazemi, M., Yanes, B., Llanses, M., Walker, H. J., Pham, K. T., Collins, M. O., Bard, F., & Rainero, E. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002406 · Cited by 67
The Close Interconnection between Mitochondrial Dynamics and Mitophagy in Cancer
Bordi, M., Nazio, F., & Campello, S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00081 · Cited by 71
MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent
Wang, T., Liu, L., Chen, X., Shen, Y., Lian, G., Shah, N., Davidoff, A. M., Yang, J. J. J., & Wang, R. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0295-5 · Cited by 64
Lee, S. Y., Ju, M. K., Jeon, H. M., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1027453 · Cited by 69
Mito-Nuclear Communication by Mitochondrial Metabolites and Its Regulation by B-Vitamins
Janssen, J. J. E., Grefte, S., Keijer, J., & de Boer, V. C. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00078 · Cited by 70
Oxygen regulation of TET enzymes
Matulevičiūtė, R., Cunha, P. P., Johnson, R. S., & Foskolou, I. P. (2021) · FEBS Journal · doi:10.1111/febs.15695 · Cited by 69
Metabolic synthetic lethality in cancer therapy
Zecchini, V. R., & Frezza, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.12.003 · Cited by 63
Self-citationMitochondrial Metabolism in Major Neurological Diseases
Zhou, Z., Austin, G. L., Young, L. E. A., Johnson, L. A., & Sun, R. C. (2018) · Cells · doi:10.3390/cells7120229 · Cited by 67
Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression
Crispo, F., Condelli, V., Lepore, S., Notarangelo, T., Sgambato, A., Esposito, F., Maddalena, F., & Landriscina, M. (2019) · Cells · doi:10.3390/cells8080798 · Cited by 63
Linking Metabolic Reprogramming, Plasticity and Tumor Progression
Shuvalov, O., Daks, A., Fedorova, O., Petukhov, A., & Barlev, N. (2021) · Cancers · doi:10.3390/cancers13040762 · Cited by 63
Tricarboxylic acid cycle metabolites in the control of macrophage activation and effector phenotypes
Noe, J. T., & Mitchell, R. A. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru1218-496r · Cited by 63
The Bidirectional Relationship Between Cancer Epigenetics and Metabolism
Izzo, L., Affronti, H. C., & Wellen, K. E. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070820-035832 · Cited by 64
Type 2 Diabetes, Obesity, and Cancer Share Some Common and Critical Pathways
Rahman, I. T., Athar, M. T., & Islam, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.600824 · Cited by 61
Cell line-directed breast cancer research based on glucose metabolism status
Farhadi, P., Yarani, R., Valipour, E., Kiani, S., Hoseinkhani, Z., & Mansouri, K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112526 · Cited by 60
Parma, B., Wurdak, H., & Ceppi, P. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100888 · Cited by 60
Shi, F., Zhou, M., Li, S., Du, Q., Li, Y., Xie, L., Liu, X., Tang, M., Luo, X., Fan, J., et al. (2019) · Theranostics · doi:10.7150/thno.30941 · Cited by 58
Mitochondria and Hypoxia: Metabolic Crosstalk in Cell-Fate Decisions
Bargiela, D., Burr, S. P., & Chinnery, P. F. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.02.002 · Cited by 60
Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy
Chen, C., Wang, Z., & Qin, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935536 · Cited by 62
Fumarate hydratase as a metabolic regulator of immunity
Peace, C. G., O’Carroll, S. M., & O'Neill, L. A. J. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.10.005 · Cited by 61
Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target
van Niekerk, G., & Engelbrecht, A. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0383-7 · Cited by 60
Sciacovelli, M., Dugourd, A. J. F., Valcárcel-Jiménez, L., Yang, M. H., Nikitopoulou, E., Costa, A. S. H., Tronci, L., Caraffini, V., Rodrigues, P., Schmidt, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35036-4 · Cited by 62
Self-citationEpigenetic determinants of metastasis
Patel, S. A., & Vanharanta, S. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.09.008 · Cited by 58
Wentzel, J. F., Lewies, A., Bronkhorst, A. J., van Dyk, E., Plessis, D., & Pretorius, P. J. (2017) · Biochimie · doi:10.1016/j.biochi.2017.01.004 · Cited by 55
Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer
Lanzetti, L. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01402-6 · Cited by 57
Wang, Q., Wu, M., Li, H., Rao, X., Ao, L., Wang, H., Yao, L., Wang, X., Hong, X., Wang, J., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106490 · Cited by 55
Menon, D. R., Hammerlindl, H., Torrano, J., Schaider, H., & Fujita, M. (2020) · Theranostics · doi:10.7150/thno.42523 · Cited by 57
Nakasuka, F., Tabata, S., Sakamoto, T., Hirayama, A., Ebi, H., Yamada, T., Umetsu, K., Ohishi, M., Ueno, A., Goto, H., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02323-7 · Cited by 54
Metabolic alterations in hereditary and sporadic renal cell carcinoma
Coffey, N. J., & Simon, M. C. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00800-2 · Cited by 56
The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy
Wu, J., Liu, N., Chen, J., Tao, Q., Li, Q., Li, J., Chen, X., & Peng, C. (2024) · Research · doi:10.34133/research.0351 · Cited by 57
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
Läsche, M., Emons, G., & Gründker, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00409 · Cited by 55
Burger, G. A., Danen, E. H. J., & Beltman, J. B. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00162 · Cited by 50
Fustaino, V., Presutti, D., Colombo, T., Cardinali, B., Papoff, G., Brandi, R., Bertolazzi, P., Felici, G., & Ruberti, G. (2017) · Oncotarget · doi:10.18632/oncotarget.21132 · Cited by 52
Auslander, N., Cunningham, C. E., Toosi, B. M., McEwen, E., Yizhak, K., Vizeacoumar, F. S., Parameswaran, S., Gonen, N., Freywald, T., Bhanumathy, K. K., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20177739 · Cited by 51
Zurlo, G., Liu, X., Takada, M., Fan, C., Simon, J. M., Ptacek, T., Rodríguez, J., von Kriegsheim, A., Liu, J., Locasale, J. W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13168-4 · Cited by 52
Role of the mitochondrial stress response in human cancer progression
Wang, S., Chen, S., Tseng, L., & Lee, H. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220920558 · Cited by 51
Involvement of Tricarboxylic Acid Cycle Metabolites in Kidney Diseases
Jiménez‐Uribe, A. P., Cruz, E. Y. H., Ramírez-Magaña, K. J., & Pedraza‐Chaverrí, J. (2021) · Biomolecules · doi:10.3390/biom11091259 · Cited by 56
Zhai, X., Liu, K., Fang, H., Zhang, Q., Gao, X., Liu, F., Zhou, S., Wang, X., Niu, Y., Hong, Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abk0490 · Cited by 53
Pharmacological significance of MitoQ in ameliorating mitochondria-related diseases
Sulaimon, L. A., Afolabi, L. O., Adisa, R. A., Ayankojo, A. G., Afolabi, M. O., Adewolu, A. M., & Wan, X. (2022) · Advances in Redox Research · doi:10.1016/j.arres.2022.100037 · Cited by 50
Targeting of stress response pathways in the prevention and treatment of cancer
Zelenka, J., Koncošová, M., & Ruml, T. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.01.007 · Cited by 50
Daniel, Y., Lelou, E., Aninat, C., Corlu, A., & Cabillic, F. (2021) · Cancers · doi:10.3390/cancers13081973 · Cited by 52
The immunometabolic ecosystem in cancer
Bantug, G. R., & Hess, C. (2023) · Nature Immunology · doi:10.1038/s41590-023-01675-y · Cited by 53
Schiavoni, V., Emanuelli, M., Milanese, G., Galosi, A. B., Pompei, V., Salvolini, E., & Campagna, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413239 · Cited by 51
Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers
Siddiqui, A., Gollavilli, P. N., Schwab, A., Vazakidou, M. E., Ersan, P. G., Ramakrishnan, M., Pluim, D., Coggins, S. A., Saatci, Ö., Annaratone, L., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0289-6 · Cited by 49
Oncometabolites in cancer aggressiveness and tumour repopulation
Dando, I., Pozza, E. D., Ambrosini, G., Torrens‐Mas, M., Butera, G., Mullappilly, N., Pacchiana, R., Palmieri, M., & Donadelli, M. (2019) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12513 · Cited by 49
Metabolic Cancer-Macrophage Crosstalk in the Tumor Microenvironment
de Goede, K. E., Driessen, A. J. M., & den Bossche, J. V. (2020) · Biology · doi:10.3390/biology9110380 · Cited by 49
Functional implications of fumarate-induced cysteine succination
Guberović, I., & Frezza, C. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.05.003 · Cited by 52
Self-citationMetabolic reprogramming: A novel therapeutic target in diabetic kidney disease
Wang, M., Pang, Y., Guo, Y., Tian, L., Liu, Y., Shen, C., Liu, M., Meng, Y., Cai, Z., Wang, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.970601 · Cited by 47
Fan, S., Price, T. T., Huang, W., Plue, M., Warren, J. L., Sundaramoorthy, P., Paul, B. A., Feinberg, D. M., MacIver, N. J., Chao, N. J. A., et al. (2020) · Advanced Science · doi:10.1002/advs.201900860 · Cited by 46
Metabolite regulation of epigenetics in cancer
Wang, P., Chen, L., Xiong, Y., & Ye, D. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114815 · Cited by 50
Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy
Zhang, H., Fan, J., Kong, D., Sun, Y., Zhang, Q., Xiang, R., Lu, S., Yang, W., Feng, L., & Zhang, H. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02460-1 · Cited by 49
Bilyard, M. K., Becker, S. M., & Balasubramanian, S. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.01.014 · Cited by 45
Zhao, X. L., & Karpac, J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.10.003 · Cited by 45
The Role of Tumor Metabolic Reprogramming in Tumor Immunity
Zhang, X., Song, W., Gao, Y., Zhang, Y., Zhao, Y., Hao, S., & Ni, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417422 · Cited by 48
Metadata
- Authors
- Sciacovelli, M., Gonçalves, E., Johnson, T. I., Zecchini, V. R., da Costa, A. S. H., Gaude, E., Drubbel, A. V., Theobald, S. J., Abbo, S. R., Tran, M. G. B., Rajeeve, V., Cardaci, S., Foster, S., Yun, H., Cutillas, P., Warren, A., Gnanapragasam, V., Gottlieb, E., Franze, K., Huntly, B., Maher, E. R., Maxwell, P. H., Saez-Rodriguez, J., & Frezza, C.
- Affiliations
- University of Cambridge (GB)
- European Bioinformatics Institute (GB)
- Queen Mary University of London (GB)
- Cancer Research UK Scotland Institute (GB)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Corresponding author
- Frezza, Christian
- ORCID
- Sciacovelli, Marco
- Gonçalves, Emanuel
- Johnson, Timothy Isaac
- Zecchini, Vincent Roberto
- Gaude, Edoardo
- Tran, Maxine Gia Binh
- Rajeeve, Vinothini
- Cardaci, Simone
- Yun, Haiyang
- Cutillas, Pedro
- Warren, Anne
- Gnanapragasam, Vincent
- Gottlieb, Eyal
- Franze, Kristian
- Huntly, Brian
- Maher, Eamonn Richard
- Maxwell, Patrick Henry
- Frezza, Christian
- Venue
- Nature
- Published
- 2016-08-31
- Volume
- 537
- Issue
- 7621
- Pages
- 544-547
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5136292
- OpenAlex
- W2513105811
- Cited by
- 584
- References
- 40
- Citations by year
- 2026: 56 · 2025: 49 · 2024: 61 · 2023: 54 · 2022: 64 · 2021: 60 · 2020: 56 · 2019: 59 · 2018: 55 · 2017: 55 · 2016: 14
- FWCI
- 25.67
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-10-19)
- Open access
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (096956/Z/11/Z)
- Cancer Research UK (18278)
- National Institute for Health and Care Research (NF-SI-0514-10122)
- Medical Research Council (MC_PC_12009, MR/M010392/1, MC_UU_12022/6)
- Cancer Research UK Cambridge Institute, University of Cambridge
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- fumarate, fumarate hydratase, epithelial-mesenchymal transition, oncometabolites, TCA cycle, DNA demethylation, histone demethylation, alpha-ketoglutarate-dependent dioxygenase, miR-200 family, miR-429, metastasis, renal cell carcinoma, hereditary leiomyomatosis and renal cell carcinoma, cell migration, epigenetic modifications
- MeSH terms
- Animals, Cell Movement, Cells, Cultured, Fumarate Hydratase, Fumarates, Humans, Kidney Neoplasms, Mesoderm, Transcription Factors, MicroRNAs, Epigenesis, Genetic, Mice, HEK293 Cells, Epithelial-Mesenchymal Transition, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
